| Registry | NCT04060628 |
|---|---|
| Status | No longer available |
| Study type | Expanded access |
| Sponsor | NanOlogy, LLC (Industry) |
| Conditions | Urogenital Neoplasms |
| Interventions | NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension (Drug) |
| Dates | first posted 2019-08-19, last updated 2026-01-23 |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Urogenital Neoplasms All trials of NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension
NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.
Sex: All
Inclusion Criteria: \- Exclusion Criteria: \-